Case Reports

Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels

University of Namur, Department of Pharmacy, Namur Research for Life Sciences, Namur Thrombosis and Hemostasis Center, Namur, Belgium; QUALIblood s.a., Namur
University of Tours, EA7501 GICC, CHRU de Tours, Department of Haemostasis, Tours
University of Tours, EA7501 GICC, CHRU de Tours, Department of Haemostasis, Tours
Département de Médecine, Hôpitaux Universitaires de Genève, service d’angiologie et d’hémostase et Faculté de Médecine, Geneva Platelet Group (GpG), Université de Genève, Geneva
University of Namur, Department of Pharmacy, Namur Research for Life Sciences, Namur Thrombosis and Hemostasis Center, Namur, Belgium; Clinique Saint-Luc Bouge, Department of Laboratory Medicine, Bouge
Service de gériatrie, CHU UCL Namur site Sainte-Elisabeth, Namur
Université Catholique de Louvain, service de gériatrie, CHU UCL Namur site Sainte-Elisabeth, Namur
CHU UCL Namur | site Sainte-Elizabeth, Université catholique de Louvain, Department of Hematology, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, Yvoir
University of Namur, Department of Pharmacy, Namur Research for Life Sciences, Namur Thrombosis and Hemostasis Center, Namur
University of Tours, EA7501 GICC, CHRU de Tours, Department of Haemostasis, Tours
University of Tours, EA7501 GICC, CHRU de Tours, Department of Haemostasis, Tours
Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory, Namur Research Institute for Life Sciences, Yvoir
Haematologica Early view Aug 12, 2021 https://doi.org/10.3324/haematol.2021.279509